Department of Anesthesiology and Pain Medicine Samsung Medical CenterSungkyunkwan University School of Medicine Seoul Korea.
Division of Cardiology Department of Medicine Heart Vascular Stroke Institute Samsung Medical CenterSungkyunkwan University School of Medicine Seoul Korea.
J Am Heart Assoc. 2021 Apr 6;10(7):e019216. doi: 10.1161/JAHA.120.019216. Epub 2021 Mar 17.
Background Perioperative blood glucose level has shown an association with postoperative outcomes. We compared the incidences of myocardial injury after noncardiac surgery (MINS) and 30-day mortality, according to preoperative blood glucose and hemoglobin A1c (HbA1c) levels. Methods and Results The patients were divided according to blood glucose level within 1 day before surgery. The hyperglycemia group was defined with fasting glucose >140 mg/dL or random glucose >180 mg/dL. In addition, we compared the outcomes according to HbA1c >6.5% among patients with available HbA1c within 3 months before surgery. The primary outcome was MINS, and 30-day mortality was also compared. A total of 12 304 patients were enrolled and divided into 2 groups: 8324 (67.7%) in the normal group and 3980 (32.3%) in the hyperglycemia group. After adjustment with inverse probability of weighting, the hyperglycemia group exhibited significantly higher incidences of MINS and 30-day mortality (18.7% versus 27.6%; odds ratio, 1.29; 95% CI, 1.18-1.42; <0.001; and 2.0% versus 5.1%; hazard ratio, 2.00; 95% CI, 1.61-2.49; <0.001, respectively). In contrast to blood glucose, HbA1c was not associated with MINS or 30-day mortality. Conclusions Preoperative hyperglycemia was associated with MINS and 30-day mortality, whereas HbA1c was not. Immediate glucose control may be more crucial than long-term glucose control in patients undergoing noncardiac surgery. Registration URL: https://www.cris.nih.go.kr; Unique identifier: KCT0004244.
围手术期血糖水平与术后结果相关。我们比较了根据术前血糖和糖化血红蛋白(HbA1c)水平,非心脏手术后心肌损伤(MINS)和 30 天死亡率的发生率。
根据手术前 1 天内的血糖水平将患者分组。空腹血糖>140mg/dL 或随机血糖>180mg/dL 定义为高血糖组。此外,我们比较了术前 3 个月内有 HbA1c 检查结果的患者中 HbA1c>6.5%的患者的结果。主要结局是 MINS,同时比较了 30 天死亡率。共纳入 12304 例患者,分为 2 组:正常组 8324 例(67.7%),高血糖组 3980 例(32.3%)。经逆概率加权调整后,高血糖组 MINS 和 30 天死亡率显著升高(18.7%比 27.6%;比值比,1.29;95%置信区间,1.18-1.42;<0.001;2.0%比 5.1%;危险比,2.00;95%置信区间,1.61-2.49;<0.001)。与血糖相比,HbA1c 与 MINS 或 30 天死亡率无关。
术前高血糖与 MINS 和 30 天死亡率相关,而 HbA1c 则不然。非心脏手术患者的即时血糖控制可能比长期血糖控制更为重要。